{"symbol": "BSTC", "companyName": "BioSpecifics Technologies Corp", "exchange": "NASDAQ Global Market", "industry": "Biotechnology", "website": "http://www.biospecifics.com", "description": "BioSpecifics Technologies Corp is a biopharmaceutical company. It is developing an injectable collagenase clostridium histolyticum for multiple indications which is marketed as XIAFLEX in the United States or Xiapex in Europe.", "CEO": "Thomas L. Wegman", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}